These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 18391177)

  • 21. The Biological Function of the Prion Protein: A Cell Surface Scaffold of Signaling Modules.
    Linden R
    Front Mol Neurosci; 2017; 10():77. PubMed ID: 28373833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prion protein NMR structure from tammar wallaby (Macropus eugenii) shows that the beta2-alpha2 loop is modulated by long-range sequence effects.
    Christen B; Hornemann S; Damberger FF; Wüthrich K
    J Mol Biol; 2009 Jun; 389(5):833-45. PubMed ID: 19393664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aged PrP null mice show defective processing of neuregulins in the peripheral nervous system.
    Benvegnù S; Gasperini L; Legname G
    Mol Cell Neurosci; 2011 May; 47(1):28-35. PubMed ID: 21334441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cells and prions: a license to replicate.
    Nuvolone M; Aguzzi A; Heikenwalder M
    FEBS Lett; 2009 Aug; 583(16):2674-84. PubMed ID: 19527722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric function and dysfunction of the prion protein.
    Linden R; Cordeiro Y; Lima LM
    Cell Mol Life Sci; 2012 Apr; 69(7):1105-24. PubMed ID: 21984610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A plausible function of the prion protein: conjectures and a hypothesis.
    Abdulla YH
    Bioessays; 2001 May; 23(5):456-62. PubMed ID: 11340627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP.
    Rambold AS; Miesbauer M; Olschewski D; Seidel R; Riemer C; Smale L; Brumm L; Levy M; Gazit E; Oesterhelt D; Baier M; Becker CF; Engelhard M; Winklhofer KF; Tatzelt J
    J Neurochem; 2008 Oct; 107(1):218-29. PubMed ID: 18691383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for an association of prion protein and sphingolipid-mediated signaling.
    Schmalzbauer R; Eigenbrod S; Winoto-Morbach S; Xiang W; Schütze S; Bertsch U; Kretzschmar HA
    J Neurochem; 2008 Aug; 106(3):1459-70. PubMed ID: 18498440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion agent diversity and species barrier.
    Béringue V; Vilotte JL; Laude H
    Vet Res; 2008; 39(4):47. PubMed ID: 18519020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CREB-dependent gene regulation by prion protein: impact on MMP-9 and beta-dystroglycan.
    Pradines E; Loubet D; Schneider B; Launay JM; Kellermann O; Mouillet-Richard S
    Cell Signal; 2008 Nov; 20(11):2050-8. PubMed ID: 18718863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From cell protection to death: may Ca2+ signals explain the chameleonic attributes of the mammalian prion protein?
    Sorgato MC; Bertoli A
    Biochem Biophys Res Commun; 2009 Feb; 379(2):171-4. PubMed ID: 19101513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural insights into alternate aggregated prion protein forms.
    Polano M; Bek A; Benetti F; Lazzarino M; Legname G
    J Mol Biol; 2009 Nov; 393(5):1033-42. PubMed ID: 19720066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Ferrari S; Benedetti D; Sbriccoli M; Rizzuto N; Monaco S
    Ann N Y Acad Sci; 2009 Jul; 1170():637-43. PubMed ID: 19686205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular pathogenesis in prion diseases.
    Crozet C; Beranger F; Lehmann S
    Vet Res; 2008; 39(4):44. PubMed ID: 18413130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prion protein and its ligand stress inducible protein 1 regulate astrocyte development.
    Arantes C; Nomizo R; Lopes MH; Hajj GN; Lima FR; Martins VR
    Glia; 2009 Oct; 57(13):1439-49. PubMed ID: 19243016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal function and morphology are altered in cattle infected with the prion disease transmissible mink encephalopathy.
    Smith JD; Greenlee JJ; Hamir AN; Richt JA; Greenlee MH
    Vet Pathol; 2009 Sep; 46(5):810-8. PubMed ID: 19429980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The toxicity of prion protein fragment PrP(106-126) is not mediated by membrane permeabilization as shown by a M112W substitution.
    Henriques ST; Pattenden LK; Aguilar MI; Castanho MA
    Biochemistry; 2009 May; 48(19):4198-208. PubMed ID: 19301918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and testing of peptides for anti-prion activity.
    Sellarajah S; Boussard C; Lekishvili T; Brown DR; Gilbert IH
    Eur J Med Chem; 2008 Nov; 43(11):2418-27. PubMed ID: 18355947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.